An international crisis could effect the stock market and could have an impact on AMBS. But bio-med stocks are immune to many things that negatively impact other stocks. For example, during the 2008 financial crisis my bio-med stocks were not nearly as impacted as the rest of the market.

Good science is going to get rewarded. If tolerance for risk taking slows down in stocks, that could limit how fast we move up, but we'll still go up.